Bambuterol: Difference between revisions
No edit summary |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Phenethylamines]] | [[Category:Phenethylamines]] | ||
[[Category:Carbamates]] {{drugs bottom}} | [[Category:Carbamates]] {{drugs bottom}} | ||
<gallery> | |||
File:Bambuterol.svg|Bambuterol | |||
File:Bambuterol ball-and-stick model.png|Bambuterol ball-and-stick model | |||
</gallery> | |||
Latest revision as of 00:45, 20 February 2025
Bambuterol is a therapeutic agent categorized as a long acting beta-adrenoceptor agonist (LABA) that serves as a primary treatment for asthma. Additionally, it functions as a prodrug for terbutaline. On the commercial front, the pharmaceutical titan AstraZeneca is responsible for producing and distributing bambuterol under the brand names Bambec and Oxeol, recognized internationally by the INN.
Therapeutic Indications[edit]
The primary therapeutic application of bambuterol, like other LABAs, revolves around the sustained management of chronic asthma. It's crucial to note that bambuterol isn't suitable for immediate relief during asthma episodes or attacks.
Contraindications[edit]
- Pregnancy: Bambuterol is not recommended for use during pregnancy.
- Liver Impairment: Individuals with severe liver dysfunction should avoid bambuterol.
- Renal Impairment: Although bambuterol can be administered to individuals with kidney issues, dosage adjustments become imperative.
Potential Adverse Effects[edit]
Bambuterol's side effect spectrum aligns closely with that of salbutamol. Patients may encounter symptoms such as fatigue, nausea, palpitations, headaches, dizziness, and potential tremors.
Drug Interactions[edit]
- Potassium Levels: Utilizing bambuterol alongside corticosteroids, diuretics, and xanthine derivatives (like theophylline) amplifies the chances of hypokalemia – a medical condition marked by reduced potassium concentrations in the bloodstream.
- Cholinesterase Inhibition: Bambuterol operates as a cholinesterase inhibitor, which can extend the action duration of suxamethonium (succinylcholine) and other drugs that rely on cholinesterase for metabolism. Butyrylcholinesterase activity is generally restored to its standard state around two weeks post the cessation of bambuterol intake.
- Neuromuscular Blocking Agents: Bambuterol can potentiate the effects of non-depolarizing neuromuscular blockers, such as the agent vecuronium bromide.
Summary[edit]
Bambuterol stands as a key therapeutic player in the realm of asthma management. As with all medications, its application should be guided by a thorough understanding of its indications, contraindications, potential side effects, and interactions with other drugs to ensure optimal patient safety and efficacy.
References[edit]
<references group="" responsive="1"></references>
|
|
|
| Drugs for obstructive airway diseases: asthma/COPD (R03) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
- Top 200 drugs
- Medicare drugs
- Canadian drugs
- Dictionary of drugs
- Encyclopedia of drugs
- List of FDA approved drugs
- List of drugs A-Z - sorted in multipage format
- Drug categories
- Drug dosage forms
- Habit forming drugs
External links[edit]
The following is the collection of detailed information and links to the National Institute of Health (NIH) comprehensive drug information portal and other reliable sources of information. Select the drug name below to show drug description, drug classification, other common drug names, and information on the reasons why prescribed, how medication should be used, and what possible side effects could occur.
Drug names[edit]
A • B • C • D • E • F • G • H • I • J • K • L • M • N • O • P • Q • R • S • T • U • V • W • X • Y • Z
Search for other drug names not listed above
-
Bambuterol
-
Bambuterol ball-and-stick model


